Evidence map›Paper›PMID 22425249›Full record

ArticleImmunity2012

E protein transcription factors are required for the development of CD4(+) lineage T cells.

Mary Elizabeth Jones-Mason, Xudong Zhao, Dietmar Kappes, Anna Lasorella, Antonio Iavarone, Yuan Zhuang

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. HEB collaborates with TCR signaling to upregulatebioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Transcriptional network dynamics in early T cell development.The Journal of experimental medicine · 2024
    Review
  8. Article
  9. Zfp281 and Zfp148 control CD4Science immunology · 2023
    Article
  10. E protein binding at theFrontiers in immunology · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mary Elizabeth Jones-MasonDepartment of Immunology, Duke University Medical Center, Durham, NC 27710, USA.
Xudong Zhao
Dietmar Kappes
Anna Lasorella
Antonio Iavarone
Yuan Zhuang
Columbia University Irving Medical Center · USDuke University Hospital · USFox Chase Cancer Center · US

Funding

HEB MEDIATED PATHWAYS AND FUNCTION IN T CELL DEVELOPMENTR01GM059638 · NIGMS · DUKE UNIVERSITY · PI CHAN, FRANCIS KAMING · 1999 to 2021
$6.9M
Control of Lineage Commitment in Developing ThymocytesR01CA153260 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI KAPPES, DIETMAR J · 2010 to 2014
$1.9M
NCI NIH HHS R01 CA153260NIGMS NIH HHS R01 GM059638NIGMS NIH HHS R01GM059638
6 · The paper itself

Abstract

The double-positive (DP) to single-positive (SP) transition during T cell development is initiated by downregulation of the E protein transcription factors HEB and E2A. Here, we have demonstrated that in addition to regulating the onset of this transition, HEB and E2A also play a separate role in CD4(+) lineage choice. Deletion of HEB and E2A in DP thymocytes specifically blocked the development of CD4(+) lineage T cells. Furthermore, deletion of the E protein inhibitors Id2 and Id3 allowed CD4(+) T cell development but blocked CD8(+) lineage development. Analysis of the CD4(+) lineage transcriptional regulators ThPOK and Gata3 placed HEB and E2A upstream of CD4(+) lineage specification. These studies identify an important role for E proteins in the activation of CD4(+) lineage differentiation as thymocytes undergo the DP to SP transition.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCD4 AntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationInhibitor of Differentiation Protein 2Inhibitor of Differentiation ProteinsInterleukin-7 Receptor alpha SubunitMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMice, TransgenicReceptors, CCR7Up-RegulationBasic Helix-Loop-Helix ProteinsCcr7 protein, mouseCD4 AntigensIdb2 protein, mouseIdb3 protein, mouseInhibitor of Differentiation Protein 2Inhibitor of Differentiation ProteinsInterleukin-7 Receptor alpha SubunitReceptors, CCR7Tcf12 protein, mouseTcf3 protein, mouse

Identifiers

PMID22425249
PMCPMC3431168
OpenAlexW2001049701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.